Form 13-F position report

LABORATORY CRP AMER HLDGS(NEW)

Reported by Thrivent Financial for Lutherans

LH CUSIP 50540R409 Manager CIK 0000314984

Reported 895,433 shares, up 873,443 (3972.0%) from the prior quarter.

Reported value 3520.0%; share count 3972.0% vs. the prior quarter.

Added
% of reported 13F value 0.56% This manager · Q2 2022
Shares 895,433 Quarter-end amount reported
Reported value $209,854,000 Fair value at quarter end
Consecutive quarters held 37 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 6583000
2022-03-31 5797000
2022-06-30 209854000
2022-09-30 168525000
2022-12-31 145737000
2023-03-31 137335000
2023-06-30 172887000
2023-09-30 156487000
2023-12-31 177096000
2024-03-31 186350000
2024-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for LABORATORY CRP AMER HLDGS(NEW) held by Thrivent Financial for Lutherans.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2024 Reduced 0 -853,015 (-100.0%) 0 $0 2024-08-13
Q1 2024 Added 853,015 +73,853 (9.5%) 0.37% $186,350,000 2024-05-14
Q4 2023 Added 779,162 +821 (0.1%) 0.39% $177,096,000 2024-02-14
Q3 2023 Added 778,341 +61,943 (8.6%) 0.37% $156,487,000 2023-11-14
Q2 2023 Added 716,398 +117,776 (19.7%) 0.39% $172,887,000 2023-08-14
Q1 2023 Reduced 598,622 -20,269 (-3.3%) 0.33% $137,335,000 2023-05-17
Q4 2022 Reduced 618,891 -203,942 (-24.8%) 0.38% $145,737,000 2023-02-08
Q3 2022 Reduced 822,833 -72,600 (-8.1%) 0.46% $168,525,000 2022-11-14
Q2 2022 Added 895,433 +873,443 (3972.0%) 0.56% $209,854,000 2022-08-16
Q1 2022 Added 21,990 +1,041 (5.0%) 0.01% $5,797,000 2022-05-13
Q4 2021 Reduced 20,949 -668 (-3.1%) 0.01% $6,583,000 2022-02-16
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1046 managers reported LABORATORY CRP AMER HLDGS(NEW) for Q2 2022.

Managers reporting LABORATORY CRP AMER HLDGS(NEW) in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 11,184,279 +1,607,500 0.08% $2,621,148,000 37 qtrs
VANGUARD GROUP INC Reduced 10,822,930 -36,198 0.07% $2,536,462,000 37 qtrs
STATE STREET CORPORATION Reduced 4,240,566 -56,540 0.06% $993,819,000 37 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 2,861,147 +128,520 0.14% $670,539,000 37 qtrs
JPMorgan Chase & Co Added 1,904,199 +633,452 0.06% $446,269,000 37 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 1,886,677 +22,461 0.06% $441,693,000 37 qtrs
Bank of America Corporation Added 1,873,309 +94,984 0.05% $439,029,000 37 qtrs
DIMENSIONAL FUND ADVISORS LP Added 1,566,758 +6,839 0.13% $367,224,000 37 qtrs
FMR LLC Added 1,365,964 +47,502 0.03% $320,127,321 37 qtrs
UBS ASSET MANAGEMENT AMERICAS INC Added 1,205,517 +124,119 0.15% $282,524,967 37 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 16, 2022
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
893,149
Shared
0
None
2,284

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.